The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Loxley PCL
SET:LOXLEY
|
TH |
|
Visteon Corp
NASDAQ:VC
|
US |
|
Sigma Healthcare Ltd
ASX:SIG
|
AU |
|
C
|
Chiyoda Corp
OTC:CHYCY
|
JP |
|
Grindrod Ltd
OTC:GRDLF
|
ZA |
|
Energy of Minas Gerais Co
BOVESPA:CMIG4
|
BR |
|
La Francaise de l Energie SA
F:LFX
|
FR |
|
Straits Trading Company Ltd
F:W2F
|
SG |
|
S
|
SBM Offshore NV
DUS:IHCB
|
NL |
|
Schneider Electric SE
PAR:SU
|
FR |
|
P
|
Phillips 66
SWB:R66
|
US |
|
R
|
Ros Agro PLC
MOEX:AGRO
|
CY |
|
Indika Energy Tbk PT
F:I41
|
ID |
|
Aryzta AG
OTC:ARZTF
|
CH |
|
Landmark REIT
SGX:D5IU
|
SG |
|
Ipsen SA
PAR:IPN
|
FR |
|
C
|
Caseys General Stores Inc
F:CS2
|
US |
|
J
|
J.M. Smucker Co
F:JM2
|
US |
|
Bank of China Ltd
HKEX:3988
|
CN |
|
Kubota Corp
F:KUO1
|
JP |
|
A
|
Astellas Pharma Inc
XMUN:YPH
|
JP |
|
I
|
IQuest Co Ltd
KOSDAQ:262840
|
KR |
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
LOXLEY does not have any price targets made by Wall Street professionals.
Over the last 13 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next -6 years is -3%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next -6 years is 2%.
Over the last 13 years, the compound annual growth rate for Operating Income has been -1%. The projected CAGR for the next -8 years is -9%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next -8 years is 36%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more